LobbyingAlveo Technologies lobbying by quarter
Alveo Technologies's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q3 2024; the issues it reports most are Medical/Disease Research/Clinical Labs.
Alveo Technologies
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2024
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$0 · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES8 reports
- SENATE4 reports
- Agriculture, Dept of (USDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| W Strategies | $0 | 8 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DARREN WILLCOX | Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | W Strategies | Under $5,000 |
| 04/18for Q1 | W Strategies | Under $5,000 |
| 01/20for Q4 2025 | W Strategies | Under $5,000 |
| 25/10/15for Q3 2025 | W Strategies | Under $5,000 |
| 25/07/18for Q2 2025 | W Strategies | Under $5,000 |
| 25/04/18for Q1 2025 | W Strategies | Under $5,000 |
| 25/01/21for Q4 2024 | W Strategies | Under $5,000 |
| 24/10/21for Q3 2024 | W Strategies | Under $5,000 |
| 24/08/16for Q3 2024 | W Strategies | Under $5,000 |